Standish M. Fleming is the board director of Ambit Biosciences Corporation since June 2001.
He is a managing member at Forward Ventures, a venture capital firm which he co-founded in 1993.
Before establishing Forward Ventures, he served as the chairman, president and chief executive officer of GeneSys Therapeutics, Inc. (merged with Somatix Therapy Corp. and subsequently acquired by Cell GeneSys, Inc.).
In his capacity as a founding managing member of Forward Ventures, Mr. Fleming has served on the board of directors and as the initial president and chief executive officer of numerous pharmaceutical and biotechnology companies.
Mr. Fleming received a B.A. from Amherst College and an M.B.A. from the University of California, Los Angeles, Graduate School of Management.